Cedars-Sinai Medical Center v. Watkins

11 F.3d 1573 (Fed. Cir. 1993) · United States Court of Appeals for the Federal Circuit · December 13, 1993

Summary

The Federal Circuit held that it had statutory jurisdiction over an appeal involving the Department of Energy’s determination under 42 U.S.C. § 5908 concerning title to an invention developed at a government facility. The court nevertheless affirmed dismissal without prejudice because Cedars-Sinai’s claims concerning its domestic patent rights were not ripe while a patent interference proceeding was pending. The court concluded that the alleged effects on Cedars-Sinai’s foreign patent rights were sufficiently fit for review but that Cedars-Sinai had not established the requisite hardship.

Court
United States Court of Appeals for the Federal Circuit
Writing for the Court
Clevenger; Archer; Michel
Jurisdiction
Federal
Decision date
December 13, 1993
Procedural posture
Appeal from the Central District of California's dismissal under Federal Rule of Civil Procedure 12(b)(1) for lack of subject-matter jurisdiction on ripeness grounds.
Standard of review
The Federal Circuit reviewed statutory appellate jurisdiction as a question of law. For ripeness, it applied Ninth Circuit law: dismissal under Rule 12(b)(1) is reviewed de novo, but factual findings on jurisdictional issues are accepted unless clearly erroneous. A factual Rule 12(b)(1) challenge permits the district court to consider extrinsic evidence, and the plaintiff bears the burden of establishing jurisdiction.
Precedential value
published precedential opinion
Parties
Cedars-Sinai Medical Center, Dr. Grundfest, Dr. Forrester, Dr. Litvack v. Watkins
Disposition
affirmed

Topics

patent lawadministrative procedure actappellate jurisdictionripenessappellate procedure

Practice areas

patent lawadministrative lawappellate procedureconstitutional law

Questions Presented

  1. Whether the Federal Circuit had exclusive statutory jurisdiction over the appeal under 28 U.S.C. § 1295(a)(1) because the district court's jurisdiction was based in part on patent jurisdiction under 28 U.S.C. § 1338(a).
  2. Whether the Department of Energy's determination under 42 U.S.C. § 5908 was ripe for judicial review while a patent interference remained pending.
  3. Whether Cedars established sufficient hardship under the second prong of the Abbott Laboratories ripeness test to invoke Article III jurisdiction.

Holdings

  1. The Federal Circuit had statutory jurisdiction over the appeal because Cedars' declaratory-judgment action necessarily implicated a hypothetical enforcement action arising under 42 U.S.C. § 5908, an Act of Congress relating to patents, thereby bringing the district court's jurisdiction within 28 U.S.C. §§ 1338(a) and 1295(a)(1).
  2. Cedars established that its challenge concerning foreign patent rights satisfied the fitness prong of the ripeness analysis, notwithstanding the pending patent interference.
  3. Cedars failed to establish hardship sufficient to satisfy the second prong of the ripeness test, so the action was not ripe for judicial review and dismissal without prejudice was proper.

Key quotations

[Section] 1338 jurisdiction ... extend[s] only to those cases in which a well-pleaded complaint establishes either that federal patent law creates the cause of action or that the plaintiff's right to relief necessarily depends on resolution of a substantial question of federal patent law, in that patent law is a necessary element of one of the well-pleaded claims. (1578)
The Supreme Court thus requires application of a two-part test to determine whether a case is ripe for judicial action: First, whether the issues are fit for judicial decision—that is, whether there is a present case or controversy between the parties; and second, whether there is sufficient risk of suffering immediate hardship to warrant prompt adjudication—that is, whether withholding judicial decision would work undue hardship on the parties. (1581)
Facts must be set forth to demonstrate that the Determination directly and substantially interferes with Cedars’ foreign licensing efforts. Conclusory statements, standing alone, are insufficient to carry Cedars’ burden to prove hardship under the second prong of the Abbott Laboratories test. (1585)

Factual background

Dr. Grundfest conducted laser-angioplasty experiments at Argonne National Laboratory, a government-owned facility operated under contract with the Department of Energy. Cedars later filed a patent application for the invention, while Dr. Gruen and Ralph Linsker filed competing applications claiming the same subject matter. During a pending patent interference concerning priority, the Department of Energy issued a determination asserting title to any invention made by Grundfest under 42 U.S.C. § 5908; Cedars did not seek administrative reconsideration. Cedars alleged that the determination impaired its domestic and foreign patent rights and its ability to license the technology.

Procedural history

Cedars challenged the Department of Energy's determination asserting United States title to an invention developed at Argonne National Laboratory and sought declaratory relief concerning ownership, statutory applicability, preemption, and the validity of the agency action. The district court dismissed the action without prejudice as unripe because a pending patent interference could determine that a party other than Cedars owned the relevant domestic patent rights. The Federal Circuit denied the government's motion to dismiss the appeal for lack of appellate jurisdiction, but affirmed the district court's dismissal because Cedars failed to establish hardship sufficient to satisfy the ripeness test.

Court Document

Open PDF
Loading document…